Open AccessTHE IMPACT OF PHARMACEUTICAL INDUSTRY ON HUMAN RIGHTS
Author(s) -
Shagufta Kanwal
Publication year - 2019
Publication title -
journal of law and social studies
Language(s) - English
Resource type - Journals
eISSN - 2709-6270
pISSN - 2709-2283
DOI - 10.52279/jlss.01.02.9098
Subject(s) - pharmaceutical industry , declaration , developing country , negotiation , argument (complex analysis) , pharmacy , obstacle , business , intellectual property , health care , law and economics , law , economic growth , economics , political science , medicine , pharmacology
Pharmaceutical industry and human rights are opposing each other and having conflict at each point relating to access to essential medicine in developing countries. At this point of research some focal points of discord and contestation from the both sectors are tried to explain. The views from pharmaceutical industry can be explained in the form of official’s submission during negotiation surrounding the Doha Declaration and the decision that were taken after the Doha Declaration. The industry’s views can also be supported by the others who paid their vital role to support the pharmaceutical industries by their writings and morally as well. The main argument given from the pharmaceutical industry was stating that patent is not creating any kind of obstacle creating any obstacle to access essential medicine in developing countries. Actually, they try to state that there were health care issues to the citizens of the developing nations before the IP protection is given to the pharmaceutical industries. So, it can be said that the progress in the field of pharmaceutical industry in the developing countries have nothing to do with IP system and the innovation in the pharmacy cannot be achieved by undermining the IP. Most of the problems in the health sector in not related to the patent system in developing countries.